Abstract
A large body of data suggest that brain cholecystokinin (CCK) systems are involved in the regulation of anxiety, and numerous studies have demonstrated that CCK-4, a CCKB agonist, reliably induces panic attacks in patients with panic disorder. Recently, pentagastrin, a commercially available CCKB agonist, has been reported to have similar anxiogenic properties. To further explore the utility of pentagastrin as a challenge agent and to determine whether its effects are dose-related, a dose-response study was conducted in ten healthy volunteers. Pentagastrin (0.2 microgram/kg, 0.6 microgram/kg and 1.0 microgram/kg) and inactive placebo were infused over one minute on four separate challenge days in a double-blind fashion. Subjects received pentagastrin while participating in a structured social interaction task. Repeated measures of anxiety, blood pressure, pulse, ACTH, and cortisol were taken at baseline and postinfusion. Pentagastrin administration led to increases in anxiety, pulse, ACTH, cortisol and physical symptoms of panic, in a dose-related manner. Participation in the social interaction task led to increases in measures of anxiety as well as increases in pulse and blood pressure. Few differences were found between the 0...Continue Reading
References
Oct 26, 1979·Science·M A Della-Fera, C A Baile
Sep 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·S A WankA de Weerth
Jul 1, 1991·Neuropeptides·K R Powell, J E Barrett
Sep 1, 1991·British Journal of Pharmacology·L SinghG N Woodruff
May 10, 1991·Brain Research·J RataudJ C Blanchard
Sep 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·J HughesG N Woodruff
Feb 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·L SinghG N Woodruff
Feb 14, 1991·European Journal of Pharmacology·J Harro, E Vasar
Jul 1, 1991·Archives of General Psychiatry·J BradwejnC Shriqui
Feb 1, 1990·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·J BradwejnG Meterissian
Jul 1, 1990·Trends in Pharmacological Sciences·S Ravard, C T Dourish
Jan 1, 1985·Annals of the New York Academy of Sciences·J N Crawley
Nov 1, 1971·Psychosomatics·W W Zung
Jun 1, 1970·Journal of Consulting and Clinical Psychology·G J Allen
Feb 10, 1984·European Journal of Pharmacology·M FeketeG Telegdy
Jul 15, 1994·Biological Psychiatry·J L AbelsonA I Vinik
Jul 15, 1994·Biological Psychiatry·J L Abelson, R M Nesse
Dec 22, 1993·The Journal of Comparative Neurology·L RinamanG E Hoffman
Sep 24, 1993·Brain Research·E S CorpG P Smith
Jun 1, 1993·Trends in Pharmacological Sciences·J HarroJ Bradwejn
Aug 1, 1993·Neuropeptides·N M RupniakS D Iversen
Citations
Mar 7, 2003·Depression and Anxiety·Lenka ZedkovaGurinder Sanghera
Jun 3, 2000·Progress in Neuro-psychopharmacology & Biological Psychiatry·K SchruersE Griez
Apr 25, 2007·Journal of Sex & Marital Therapy·Kenneth R KaufmanMatthew Menza
Jul 5, 2007·The Annals of Pharmacotherapy·Giovanni PolimeniAchille P Caputi